MLTX Stock Analysis: Buy, Sell, or Hold?
MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
$20.41
0.05 (0.25%)
▲
5d:
+8.1%
30d:
+16.7%
90d:
+13.64%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 6.5/10
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
14 traders called MLTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MLTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MLTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $20.41, which is considered extended relative to its 30-day fair value range of $18.23 to $20.35.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $18.46, while resistance sits at $21.28.
Market Sentiment: MLTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.00 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $18.46, while resistance sits at $21.28.
Market Sentiment: MLTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.00 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.23 -
$20.35
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.2% below Wall St target ($28.00)
Trading Range Analysis
30-Day Trading Range
$18.23 -
$20.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$18.46
Resistance Level
$21.28
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.95
Wall Street Target
$28.00
(+37.2%)
Share & Embed Analysis
Last updated: July 13, 2026 6:25 PM ET
Data refreshes hourly during market hours. Next update: 7:24 PM
Data refreshes hourly during market hours. Next update: 7:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Da Silva Jorge Santos
SELL
51873 shares
2026-04-13
Da Silva Jorge Santos
SELL
98127 shares
2026-04-10
Bvf Partners L P/Il
SELL
3750000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.
